A SIMPLE KEY FOR AGEN EURO UNVEILED

Emily Bodnar’s ranking relies around the anticipation of important milestones for Agenus in the coming year, notably the potential submitting of the Biologics License Software (BLA) for his or her lead drug prospect, botensilimab (bot). Agenus has dosed over 900 patients with bot across different sound tumors, exhibiting a motivation to comprehen